Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
524632-BOM Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High ROE but declining trend
High operating margin but declining trend
Company's earnings are of moderate quality
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - IV).
Snapshot
See detailed analysis
524632-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
524632-BOM Bulk, Block & Insider Trades
524632-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Rights issue
Stock split
Others
Bonus(3 new shares for 1 existing shares) Ex-date: 19th Apr 2024 Announced on: 29th Feb 2024
Rights issue(6 new shares @ 20 INR for 1 existing shares)"Rights ISIN INE551C20028SEDOL BNKCHB6." Ex-date: 2nd Feb 2023 Announced on: 18th Jan 2023
Stock split(1 : 10)Nominal Value changes from INR 10 to INR 1. Ex-date: 21st Mar 2025 Announced on: 7th Mar 2025
Capital Reduction (CRD) Ex-date: 10th Mar 2014 Announced on: 3rd Mar 2014
Company Profile
Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume p... Read More
Key personnel
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Shukra Pharmaceuticals Ltd.?
The current share price of Shukra Pharmaceuticals Ltd. is ₹ 47.30 as of 09 Jan 2026.
What is the PE ratio of Shukra Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Shukra Pharmaceuticals Ltd. is 204.68 as of the latest financial data.
What is the ROE and ROCE of Shukra Pharmaceuticals Ltd.?
Shukra Pharmaceuticals Ltd. has a Return on Equity (ROE) of 16.85% and a Return on Capital Employed (ROCE) of 15.98% as per the latest financial reports.
What is the market cap of Shukra Pharmaceuticals Ltd.?
The market capitalization of Shukra Pharmaceuticals Ltd. stands at ₹ 2,071.17 Cr.
What is the dividend yield of Shukra Pharmaceuticals Ltd.?
The dividend yield of Shukra Pharmaceuticals Ltd. is 0.02% based on the current market price.
What is the RSI of Shukra Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Shukra Pharmaceuticals Ltd. is 41.72.
What is the FII and DII holding in Shukra Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.11% of Shukra Pharmaceuticals Ltd. shares.
What sector does Shukra Pharmaceuticals Ltd. belong to?
Shukra Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Shukra Pharmaceuticals Ltd. stock?
The beta of Shukra Pharmaceuticals Ltd. stock is -0.11, indicating its volatility relative to the broader market.
